Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Radian Group Inc    RDN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Radian Group Inc : Radian Group Inc. And Keryx Biopharmaceuticals News: (NYSE: RDN), (NASDAQ; KERX)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/22/2013 | 07:30am CEST

New York (April 22nd, 2013) - Radian Group Inc. (NYSE: RDN) announced that it will hold a conference call on Wednesday, May 1, 2013, at 11:00 a.m. Eastern time to discuss the company?s first quarter results, which will be announced prior to the market open on the same day.

Radian Group Inc. (RDN), headquartered in Philadelphia, provides private mortgage insurance and related risk mitigation products and services to mortgage lenders nationwide through its principal operating subsidiary, Radian Guaranty Inc. These services help promote and preserve homeownership opportunities for homebuyers, while protecting lenders from default-related losses on residential first mortgages and facilitating the sale of low-downpayment mortgages in the secondary market.

Find out more on RDN here:

http://www.wallstreetscoop.net/market-scan/?symbol=RDN


Keryx Biopharmaceuticals (NASDAQ:KERX) traded at $ 8.03 in the last session, which is +0.42 (5.52%). The stock has a Range of 7.58 - 8.06. The stock has a 52 week low and high of 1.30 - 9.98 respectively. The stock has a Market Cap of 655.90M. The stock traded a volume of 2.32M. The stock has a 30 day average volume of 2.74M.

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes.

Find out if KERX could maintain its gaining momentum here:

http://www.wallstreetscoop.net/market-scan/?symbol=KERX


About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
[email protected]
347-905-5009


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RADIAN GROUP INC
04/27 RADIAN : Earnings Improve, Book Expands at Radian
04/27 RADIAN GROUP INC. (NYSE : RDN) Files An 8-K Results of Operations and Financial ..
04/27 RADIAN GROUP INC : Results of Operations and Financial Condition, Financial Stat..
04/27 RADIAN : misses 1Q profit forecasts
04/27 RADIAN : Announces First Quarter 2017 Financial Results
04/18 RADIAN : Extends Exclusive Partnership with Asian Real Estate Association of Ame..
04/15 RADIAN GROUP INC. : Moves Lower on Volume Spike for April 13
04/13 RADIAN : to Webcast First Quarter Conference Call on April 27, 2017
03/23 VALUAMERICA : Partners with Pavaso to Upgrade Closings with Hybrid Digital Mortg..
03/21 RADIAN : Red Bell Real Estate and Pyramid Platform Receive MOR RV1 Residential-V..
More news
Sector news : Property & Casualty Insurance - NEC
04/27DJSAMPO OYJ : Decisions Of Sampo Plc's Annual General Meeting
04/26 Canadian pension fund CPPIB targets new investment avenues in India
04/13 Wells Fargo's profit flat as costs, mortgages weigh
04/12DJBERKSHIRE HATHAWAY : to Sell Nine Million Wells Fargo Shares
04/11DJLOEWS : Seeking a Business That Can't Be Disrupted, Pays $1.2 Billion to Buy Bai..
More sector news : Property & Casualty Insurance - NEC
News from SeekingAlpha
04/27 Radian's (RDN) CEO Rick Thornberry on Q1 2017 Results - Earnings Call Transcr..
04/27 FINANCIALS - TOP 5 GAINERS / LOSERS : 05 pm
04/27 Radian plunges 10% after Q1 disappoints; drags down other MI players
04/27 Radian Group, Inc. 2017 Q1 - Results - Earnings Call Slides
04/27 Radian Group misses by $0.06, misses on net premiums earned
Advertisement
Financials ($)
Sales 2017 965 M
EBIT 2017 569 M
Net income 2017 388 M
Debt 2017 -
Yield 2017 0,06%
P/E ratio 2017 9,79
P/E ratio 2018 8,69
Capi. / Sales 2017 4,14x
Capi. / Sales 2018 3,78x
Capitalization 3 997 M
More Financials
Chart RADIAN GROUP INC
Duration : Period :
Radian Group Inc Technical Analysis Chart | RDN | US7502361014 | 4-Traders
Full-screen chart
Technical analysis trends RADIAN GROUP INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 21,3 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Richard G. Thornberry Chief Executive Officer & Director
Herbert Wender Non-Executive Chairman
J. Franklin Hall Chief Financial Officer & Executive Vice President
Richard I. Altman Chief Information Officer & Executive VP
David Charles Carney Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RADIAN GROUP INC-4.45%3 997
BERKSHIRE HATHAWAY INC..2.39%410 941
TRAVELERS COMPANIES IN..-0.21%34 133
TOKIO MARINE HOLDINGS ..-1.48%32 025
ALLSTATE CORP10.60%29 939
SAMPO OYJ9.93%28 193
More Results